MedPath

Collect therapy coil electrograms from insulation breaches study

Completed
Conditions
Implanted defibrillator lead high-voltage insulation breach
Circulatory System
Registration Number
ISRCTN10583311
Lead Sponsor
Medtronic, Inc. (USA)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
25
Inclusion Criteria

1. Subject (or subject’s legally authorized representative) is willing and able to provide written informed consent
2. Subject is at least 18 years of age (or older, if required by local law)
3. Subject is willing and able to wear a Holter monitor for at least 2 hours and up to 24 hours
4. Subject has been implanted with a Medtronic ICD or CRT-D device
5. Subject’s defibrillator lead has a possible high voltage insulation breach, as suggested by device diagnostics exhibiting any of the following three characteristics:
5.1. Abrupt high voltage impedance decrease (25% decrease in daily impedance from baseline)
5.2. Non-physiologic noise on high voltage EGM
5.3. Less than 50% programmed shock energy delivered

Exclusion Criteria

1. Subject has medical conditions that would limit study participation (per physician discretion)
2. Subject is enrolled in one or more concurrent studies that would confound the study results of this study as determined by Medtronic

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ead insulation breaches in the high-voltage portion of defibrillation leads, measured using EGM data at any time between the end of Holter monitor use to up to 180 days post-Holter use
Secondary Outcome Measures
NameTimeMethod
There are no secondary outcome measures for this study
© Copyright 2025. All Rights Reserved by MedPath